Literature DB >> 8916297

Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis.

R Badolato1, J J Oppenheim.   

Abstract

Rheumatoid arthritis (RA) has no firm etiologic basis. It progresses as an autoimmune disease and evolves into a chronic inflammatory joint disease complicated by recurrent episodes of systemic acute-phase reactions, which sometimes result in amyloidosis. Cytokines play a pivotol role in inflammation and the immune response. Proinflammatory cytokines such as interleukin-1, tumor necrosis factor alpha (TNF-alpha), and interleukin-6 are present at high levels in arthritic joints, and their blood concentration correlates with the severity of the RA. Some of the activities of the proinflammatory cytokines, such as stimulation of leukocyte infiltration and release of their proteolytic enzymes, may be mediated by acute phase proteins (APPs), such as C-reactive protein and serum amyloid A, and by chemokines such as interleukin-8. Cytokines, chemokines, and APPs reciprocally regulate each others' expression and activities, constituting a communication network between fibroblasts, macrophages, lymphocytes, and hepatocytes. Activation of the network results in inflammation and the progressive destruction of joints and systemic symptoms characteristic of RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916297     DOI: 10.1016/s0049-0172(96)80041-2

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  32 in total

1.  Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.

Authors:  G Lisignoli; A Piacentini; S Toneguzzi; F Grassi; B Cocchini; A Ferruzzi; G Gualtieri; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis.

Authors:  Susumu Nishiyama; Tetsushi Aita; Yasuhiko Yoshinaga; Hiroki Kishimoto; Michio Toda; Yoshiki Yoshihara; Shinya Miyoshi; Akira Manki; Shoji Miyawaki
Journal:  Rheumatol Int       Date:  2011-07-26       Impact factor: 2.631

Review 3.  Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis.

Authors:  H Baumann; I Kushner
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 4.  Inflammation and rheumatoid arthritis.

Authors:  Amit Kumar Shrivastava; Aparna Pandey
Journal:  J Physiol Biochem       Date:  2012-10-31       Impact factor: 4.158

5.  Expression and function of wingless and frizzled homologs in rheumatoid arthritis.

Authors:  M Sen; K Lauterbach; H El-Gabalawy; G S Firestein; M Corr; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

6.  Concentration of acute phase factors in vitreous fluid in diabetic macular edema.

Authors:  Kazuhiro Kimura; Tomoko Orita; Yuka Kobayashi; Shigeo Matsuyama; Kazushi Fujimoto; Kazuhiko Yamauchi
Journal:  Jpn J Ophthalmol       Date:  2017-07-28       Impact factor: 2.447

7.  Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids.

Authors:  I Torsteinsdóttir; N G Arvidson; R Hällgren; L Håkansson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

8.  Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells.

Authors:  Wen-Chuan Wu; Dan-Ning Hu; Hua-Xin Gao; Min Chen; Dawei Wang; Richard Rosen; Steven A McCormick
Journal:  Mol Vis       Date:  2010-09-12       Impact factor: 2.367

9.  Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand.

Authors:  Atsuo Sakurai; Nobuo Okahashi; Ichiro Nakagawa; Shigetada Kawabata; Atsuo Amano; Takashi Ooshima; Shigeyuki Hamada
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Regulation of CCR5 expression and MIP-1alpha production in CD4+ T cells from patients with rheumatoid arthritis.

Authors:  C R Wang; M F Liu
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.